FDA has approved the new furosemide injection for treating edema in adults with chronic heart failure. Lasix ONYU was developed to enable subcutaneous infusion of furosemide outside the healthcare setting for selected patients, as prescribed by a clinician without the need for a healthcare professional to administer the drug. About 6.7 million Americans suffer from […]
Intensity-modulated radiotherapy is as good as proton beam therapy for treating people with head and neck cancer, according to the results of a Cancer Research UK-funded clinical trial. The TORPEdO trial funded by Cancer Research UK and The Taylor Family Foundation, led by The Christie NHS Foundation Trust and sponsored by the Institute of Cancer […]
Researchers have discovered in a new study that irritable bowel syndrome (IBS) patients have a much greater long-term risk of acquiring inflammatory bowel disease (IBD) than the general population. The study concluded that IBS patients, particularly those with the diarrhea-predominant subtype (IBS-D), had a higher risk of developing ulcerative colitis (UC) or Crohn’s disease (CD) […]
China: Researchers have found that a higher stress hyperglycemia ratio (SHR) is strongly associated with an increased risk of acute respiratory distress syndrome (ARDS) and in-hospital mortality among patients with sepsis. The study, published in Scientific Reports, analyzed data from 1,946 sepsis patients and highlighted that individuals in the highest SHR quartile faced a 42% […]
Researchers have found in a new study that in patients with nonvalvular atrial fibrillation (AF) and atherosclerosis, the addition of antiplatelet therapy to anticoagulants did not reduce ischemic events but significantly increased bleeding risk. Researchers conclude that anticoagulant monotherapy may be a safer option for this high-risk population. The study was published in JAMA Neurology […]
Chennai: Officials from the Tamil Nadu Drugs Control Department uncovered horrific conditions at the Sresan Pharmaceuticals unit in Kancheepuram, where the now-banned Coldrif cough syrup was manufactured. The raid exposed open vats of boiling chemicals, leaking rusted pipes, and workers handling toxic substances without masks or gloves, a scene investigators described as a “factory of […]
According to a new study, Patients with atopic dermatitis (AD) treated with dupilumab have a lower risk of developing otitis media and needing related surgical procedures compared to those treated with pimecrolimus. The study was published in Pediatric Dermatology journal by Matthew H. and colleagues. The findings highlight dupilumab’s added benefit beyond skin disease management, […]
Netherlands: A new study has shown that eye movement desensitization and reprocessing (EMDR) therapy led to significant reductions in personality disorder (PD) symptoms, with nearly half of the participants achieving diagnostic remission, highlighting its potential as an effective treatment option. Personality disorders affect a substantial portion of the population […]
According to a new study published in JAMA, in unselected patients with acute myocardial infarction, routine Helicobacter pylori screening did not significantly lower the risk of upper gastrointestinal (GI) bleeding. The study was published by Robin H. and colleagues. Upper GI bleeding is an established complication following myocardial infarction and frequently attributed to the anticoagulant […]
The FDA has approved oral remibrutinib as the first BTK inhibitor for chronic spontaneous urticaria in adults not responding to antihistamines. Rhapsido is a pill taken twice daily and does not require injections or lab monitoring. It is the first FDA-approved Bruton’s tyrosine kinase inhibitor (BTKi) for CSU. Rhapsido helps to inhibit the release of […]